Published in Pathog Dis on October 02, 2015
Bacterial Toxins as Pathogen Weapons Against Phagocytes. Front Microbiol (2016) 0.77
Albumin, in the presence of calcium, elicits a massive increase in extracellular Bordetella adenylate cyclase toxin. Infect Immun (2017) 0.75
Bacterial toxins: Offensive, defensive, or something else altogether? PLoS Pathog (2017) 0.75
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med (2001) 12.38
Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol (2010) 6.88
Understanding the IL-23-IL-17 immune pathway. Trends Immunol (2005) 6.79
Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell (1990) 4.47
Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol (2003) 4.45
Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science (1982) 4.10
TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J Immunol (2006) 3.44
Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biol (2012) 3.39
Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun (1993) 3.04
Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res (2010) 2.82
Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J Exp Med (1991) 2.79
Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol (1996) 2.41
Airborne transmission of Bordetella pertussis. J Infect Dis (2012) 2.34
The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med (2001) 2.12
NETosis: how vital is it? Blood (2013) 2.11
Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol (2003) 1.96
Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol (2002) 1.88
Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection. Infect Immun (1999) 1.83
Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J Exp Med (1994) 1.81
Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J Exp Med (1997) 1.81
Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis (2008) 1.68
Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. J Immunol (1985) 1.56
Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog (2013) 1.54
The inhibition of neutrophil granule enzyme secretion and chemotaxis by pertussis toxin. J Cell Biol (1985) 1.53
Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect Immun (2000) 1.52
Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J Immunol (2010) 1.48
Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions. Infect Immun (1987) 1.48
Bordetella adenylate cyclase toxin: a swift saboteur of host defense. Curr Opin Microbiol (2006) 1.47
Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin. J Immunol (1987) 1.45
Nonhuman primate model of pertussis. Infect Immun (2012) 1.45
Changing pertussis epidemiology: everything old is new again. J Infect Dis (2014) 1.43
Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol (2014) 1.40
Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation. J Immunol (1989) 1.38
Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol (2012) 1.37
Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest (2005) 1.32
Pertussis toxin plays an early role in respiratory tract colonization by Bordetella pertussis. Infect Immun (2003) 1.26
Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS One (2009) 1.25
Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect Immun (1998) 1.24
Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect Immun (2005) 1.23
Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28. Eur J Immunol (1998) 1.19
Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol (2012) 1.18
Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infect Immun (2010) 1.17
Pertussis toxin-sensitive factor differentially regulates lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production in mouse peritoneal macrophages. J Immunol (1993) 1.16
Efficient neutrophil extracellular trap induction requires mobilization of both intracellular and extracellular calcium pools and is modulated by cyclosporine A. PLoS One (2014) 1.16
Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tract. Infect Immun (2005) 1.16
Overview of the interleukin-1 family of ligands and receptors. Semin Immunol (2013) 1.15
Pertussis: challenges today and for the future. PLoS Pathog (2013) 1.15
Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun (2005) 1.13
The ins and outs of pertussis toxin. FEBS J (2011) 1.12
Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect Immun (1997) 1.12
Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses. J Immunol (2008) 1.12
Re-emergence of pertussis: what are the solutions? Expert Rev Vaccines (2012) 1.11
Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion. Immunol Res (2002) 1.11
RTX cytotoxins recognize beta2 integrin receptors through N-linked oligosaccharides. Proc Natl Acad Sci U S A (2008) 1.10
Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun (2000) 1.09
Newly secreted adenylate cyclase toxin is responsible for intoxication of target cells by Bordetella pertussis. Mol Microbiol (2004) 1.07
Fc receptor-mediated immunity against Bordetella pertussis. J Immunol (2001) 1.07
Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. J Infect Dis (2001) 1.05
Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice. Infect Immun (2008) 1.03
Phagocytosed Bordetella pertussis fails to survive in human neutrophils. Infect Immun (2000) 1.02
Bordetella pertussis fimbriae bind to human monocytes via the minor fimbrial subunit FimD. J Infect Dis (1995) 1.02
The role of Toll-like receptor-4 in pertussis vaccine-induced immunity. BMC Immunol (2008) 0.99
Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways. PLoS One (2010) 0.99
Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection. Infect Immun (2012) 0.97
Phagocytosis of Bordetella pertussis incubated with convalescent serum. J Infect Dis (2003) 0.97
Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanisms. Pediatr Pulmonol (2009) 0.96
Possible options for new pertussis vaccines. J Infect Dis (2014) 0.95
Role of pertussis toxin A subunit in neutrophil migration and vascular permeability. Infect Immun (1997) 0.94
A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines. Infect Immun (2000) 0.94
Involvement of BLT1 endocytosis and Yes kinase activation in leukotriene B4-induced neutrophil degranulation. J Immunol (2005) 0.92
Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies. Vaccine (2013) 0.91
Delayed role of tumor necrosis factor- alpha in overcoming the effects of pertussis toxin. J Infect Dis (2007) 0.91
Lectin site ligation of CR3 induces conformational changes and signaling. J Biol Chem (2011) 0.91
Role of neutrophils in response to Bordetella pertussis infection in mice. Infect Immun (2008) 0.90
The virulence factors of Bordetella pertussis: talented modulators of host immune response. Arch Immunol Ther Exp (Warsz) (2013) 0.89
Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis. Infect Immun (2010) 0.89
Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection. Infect Immun (2013) 0.88
Variability in the lipooligosaccharide structure and endotoxicity among Bordetella pertussis strains. J Infect Dis (2010) 0.88
N-Formyl peptide receptor ligation induces rac-dependent actin reorganization through Gbeta gamma subunits and class Ia phosphoinositide 3-kinases. J Biol Chem (2000) 0.87
Inhibition of neutrophil apoptosis by PAI-1. Am J Physiol Lung Cell Mol Physiol (2011) 0.87
Cyclic AMP-mediated suppression of neutrophil extracellular trap formation and apoptosis by the Bordetella pertussis adenylate cyclase toxin. Infect Immun (2014) 0.86
Toll-like receptor 4 orchestrates neutrophil recruitment into airways during the first hours of Bordetella pertussis infection. Microbes Infect (2013) 0.86
Cholesterol-rich domains are involved in Bordetella pertussis phagocytosis and intracellular survival in neutrophils. Microb Pathog (2008) 0.86
A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine. Mucosal Immunol (2014) 0.84
Wnt5a stimulates chemotactic migration and chemokine production in human neutrophils. Exp Mol Med (2013) 0.83
Filamentous hemagglutinin of Bordetella pertussis: a key adhesin with immunomodulatory properties? Future Microbiol (2014) 0.82
Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice. J Immunol (2011) 0.81
Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro. Infect Immun (1994) 0.79
Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. Vaccine (2012) 0.79
Interaction of Bordetella adenylate cyclase toxin with complement receptor 3 involves multivalent glycan binding. FEBS Lett (2014) 0.79
Pertussis: pertussis control strategies and the options for improving current vaccines. Expert Rev Vaccines (2014) 0.77
Extracellular NAD(+) inhibits human neutrophil apoptosis. Apoptosis (2014) 0.76